Search
for

    Sort by

    Research 121–150 of 1000+

    1. An urticarial drug eruption caused by tofacitinib for alopecia universalis Dermatologic Therapy · 2019 · 2 citations
    2. Multi-functional engineered polypeptide-based drug delivery systems for improved cancer therapy Green Chemical Engineering · 2022 · 11 citations
    3. FDA declines approval of testosterone drug for third time ˜The œLancet. Diabetes & endocrinology · 2013 · 2 citations
    4. Effectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia Biomedical & Pharmacology Journal · 2025
    5. Nanospanlastic as a promising nanovesicle for drug delivery Elsevier eBooks · 2022
    6. 1P-230: Synthesis and in vitro characterization of 68 Ga labeled Fe 3 O 4 nanoparticles for drug delivery 한국공업화학회 연구논문 초록집 · 2016
    7. The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development Frontiers in Molecular Neuroscience · 2023 · 13 citations
    8. Dissolving microneedle patch loading dutasteride microspheres for the long-acting treatment of androgenetic alopecia Journal of Drug Delivery Science and Technology · 2025
    9. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome Urology · 2018 · 35 citations
    10. Topical imiquimod—Be aware of the unexpected Journal of The American Academy of Dermatology · 2016 · 3 citations
    11. Reporting on Adverse Clinical Events Clin-Alert · 2015
    12. Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness? Skin appendage disorders · 2019 · 14 citations
    13. Post‐finasteride syndrome: real or myth? Trends in Urology & Men s Health · 2024
    14. Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy Annals of Neurology · 2003 · 30 citations
    15. Controversies in the treatment of androgenetic alopecia: The history of finasteride Dermatologic Therapy · 2018 · 13 citations
    16. Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer Journal of thoracic oncology · 2006 · 12 citations
    17. The postfinasteride syndrome; an overview Journal of Mind and Medical Sciences · 2016 · 6 citations
    18. Delayed onset perforating folliculitis associated with sorafenib Australasian journal of dermatology · 2014 · 5 citations
    19. Smart stimuli-responsive microneedle platforms for precision androgenetic alopecia therapy: Materials strategy and therapeutic perspectives Materials Today Chemistry · 2026
    20. Finasteride: risk of suicidality and depression Reactions Weekly · 2025
    21. Psoriasis Drugs & Therapy Perspectives · 1994
    22. Have the facts on topical minoxidil been smoothed over? Inpharma (Balgowlah) · 1987
    23. Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy Dermatology · 2002 · 35 citations
    24. Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study Cureus · 2023
    25. Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery Medicines · 2018 · 27 citations
    26. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain Clinical Drug Investigation · 2017 · 8 citations
    27. Minoxidil-induced hypertrichosis in a child with alopecia areata Indian Dermatology Online Journal · 2017 · 4 citations
    28. Many sexual adverse effects of finasteride are attributable to a nocebo effect Nature Clinical Practice Urology · 2008 · 1 citations
    29. A Study on the Usage and Perception of Scalp Tonic and Minoxidil among Individuals Experiencing Stress-Induced Hair Loss 한국인그리에학회지 · 2023
    30. Albendazole-induced anagen effluvium: a brief literature review and our own experience Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2020 · 2 citations